MARKET

HCM

HCM

Chi-Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.12
-0.63
-3.19%
Closed 16:14 10/18 EDT
OPEN
19.75
PREV CLOSE
19.75
HIGH
19.80
LOW
18.66
VOLUME
233.56K
TURNOVER
--
52 WEEK HIGH
39.68
52 WEEK LOW
16.47
MARKET CAP
2.55B
P/E (TTM)
-290.5775
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HCM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HCM News

  • Chi-Med Highlights Publication of Phase II Data Showing Promising Efficacy for Savolitinib in Met-amplified Gastric Cancers
  • Benzinga.4d ago
  • Chi-Med highlights publication of Phase II data showing promising efficacy for Savolitinib in MET-amplified gastric cancers
  • GlobeNewswire.4d ago
  • Week In Review: Jiangsu's CTFH Signs $200-Million AI Drug Discovery Pact With Insilico
  • Seeking Alpha - Article.10/14 06:29
  • Edison issues ADR update on Hutchison China MediTech (HCM)
  • ACCESSWIRE.10/10 12:45

More

Industry

Pharmaceuticals
-0.90%
Pharmaceuticals & Medical Research
-0.94%

Hot Stocks

Name
Price
%Change

About HCM

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.
More

Webull offers Hutchison China MediTech Limited (HCM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.